advertisement
Abstract #19252 Published in IGR 9-3
Neuro-hormonal regulation of aqueous humor dynamics as the basis of glaucoma pharmacotherapy Part I. Aqueous humor secretion
Terelak-Borys B; Liberek IKlinika Oczna 2007; 109: 60-63
The aim of this article is to present current opinion on aqueous humor dynamics regulation and antiglaucoma drugs mechanisms of action. Glaucoma pharmacotherapy is based mainly on neuro-hormonal processes controlling aqueous humor dynamics. Systemic hormones as well as local hormones and autonomic nervous system mediators are involved in the processes of aqueous humor formation and drainage. Antiglaucoma medications act mainly through activation or inhibition of these systems' receptors, helping to decrease aqueous humor production or improve aqueous humor outflow. In this article (part 1) we describe three groups of antiglaucoma medications (beta-antagonists, adrenergic agonists, carbonic anhydrase inhibitors), inhibiting the aqueous humor production and mechanisms of their hypotensive effect in the eye. LA: Polish
Dr. B. Terelak-Borys, Klinika Okulistyki, Centrum Medycznego Ksztalcenia Podyplomowego, SPSK Im. Prof. W. Orlowskiego, ul. Czerniakowska 231, 00-416 Warszawa, Poland
Classification:
11.1 General management, indication (Part of: 11 Medical treatment)
3.8 Pharmacology (Part of: 3 Laboratory methods)
